Several outlets report that some people who lose weight using GLP-1 drugs are seeking cosmetic breast procedures afterward, describing visible sagging and changes in breast size and shape they attribute to weight-loss effects often discussed online as “jab sag.” The coverage frames the trend as a response to dissatisfaction with a more “deflated” appearance and a desire for a different silhouette.
The articles describe cosmetic options and the practical considerations doctors face when performing breast surgery after GLP-1 use. They state that surgical planning is presented as more complicated in this context, and they discuss approaches aimed at achieving natural-looking results. One key point highlighted is the suggestion that patients may need to stop GLP-1 medications before surgery, though the specific timing and medical guidance can vary by clinician and individual risk factors.
Overall, the outlets’ focus differs mainly in emphasis: some highlight patient motivations and aesthetic goals, while others stress the operational and medical aspects of planning surgery in the post–GLP-1 period.
